Structural basis for constitutive activation of oncogenic gp130 mutants found in human inflammatory hepatocellular adenomas
Inflammatory hepatocellular adenomas (IHCAs) are benign liver tumors primarily driven by somatic mutations in the gp130 receptor, resulting in its constitutive activation. To uncover the structural mechanisms underlying this activation, we employ cryo-electron microscopy and mutagenesis to study five representative IHCAs-associated gp130 mutants and two engineered mutants with ligand-independent activity. Most mutants form “X”-shaped dimers through a 3D domain-swapping mechanism, characterized by large separations between juxtamembrane domains and reliant on D1 domain-mediated “tip-to-tip” interactions for dimer clustering and activation. A rare mutant displays a distinct “Y”-shaped dimer conformation, with closely aligned juxtamembrane domains enabling direct activation independent of dimer clustering. These findings highlight the diversity of gp130 mutant activation mechanisms and provide a foundation for developing therapeutic strategies targeting aberrant gp130 signaling in IHCAs.
Authors
- Matthew C. Franklin (ORCID: https://orcid.org/0000-0002-1482-0136)
- Jennifer L. Jones (ORCID: https://orcid.org/0000-0003-0472-2994)
- William C. Olson (ORCID: https://orcid.org/0000-0001-6254-0641)
- Raymond Leidich
- Trudy F. Ramlall
- Mark W. Sleeman (ORCID: https://orcid.org/0000-0002-3329-0919)
- Annan SI Cook (ORCID: https://orcid.org/0000-0001-6415-9107)
- Luke L. McGoldrick (ORCID: https://orcid.org/0000-0002-8310-7502)
- Jing Cao (ORCID: https://orcid.org/0000-0002-9425-9982)
- Yi Zhou (ORCID: https://orcid.org/0000-0002-1650-4591)
- Panayiotis E. Stevis
Institutions
- Regeneron (United States) (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1038/s41467-026-79742-9
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00